cyclophosphamide
Showing 1 - 25 of 2,369
Influence of Timing PTCy in AlloSCT
Not yet recruiting
- Cyclophosphamide Toxicity
- Allogenic Haematopoetic Transplantation
- Cyclophosphamide
- (no location specified)
Jun 6, 2023
Multiple Myeloma in Relapse, Multiple Myeloma, Refractory Trial (Carfilzomib, Cyclophosphamide, Dexamethasone)
Not yet recruiting
- Multiple Myeloma in Relapse
- Multiple Myeloma, Refractory
- Carfilzomib
- +2 more
- (no location specified)
Jun 8, 2023
Breast Tumors Trial in Shanghai (Epirubicin, Docetaxel, cyclophosphamide)
Completed
- Breast Neoplasms
- Epirubicin
- +2 more
-
Shanghai, Shanghai, ChinaRuijin Hospital
Oct 26, 2022
Hemophagocytic Syndrome Trial in Chongqing (cyclophosphamide, VP-16, Dexamethasone)
Recruiting
- Hemophagocytic Syndrome
- cyclophosphamide
- +3 more
-
Chongqing, ChinaThe Second affiliated Hosptial of Chongqing medical University
Jun 28, 2023
Graft Vs Host Disease Trial in Puebla (Cyclophosphamide)
Enrolling by invitation
- Graft Vs Host Disease
- Cyclophosphamide
-
Puebla, MexicoCentro de Hematología y Medicina Interna
Mar 22, 2023
Hematologic Malignancies Trial in Los Angeles (Cyclophosphamide)
Not yet recruiting
- Hematologic Malignancies
- Cyclophosphamide
-
Los Angeles, CaliforniaCedars-Sinai Medical Center
May 5, 2023
Relapsed/Refractory Large B Cell Lymphoma Trial (biological, drug, genetic)
Not yet recruiting
- Relapsed/Refractory Large B Cell Lymphoma
- ALLO-647
- +3 more
- (no location specified)
Feb 6, 2023
Ovarian Cancer Trial in Houston (Pembrolizumab, Bevacizumab, Cyclophosphamide)
Not yet recruiting
- Ovarian Cancer
- Pembrolizumab
- +2 more
-
Houston, TexasMD Anderson Cancer Center
Oct 9, 2023
Anatomic Stage I Breast Cancer AJCC v8, Anatomic Stage II Breast Cancer AJCC v8, Anatomic Stage III Breast Cancer AJCC v8 Trial
Recruiting
- Anatomic Stage I Breast Cancer AJCC v8
- +3 more
- Cyclophosphamide
- +3 more
-
Duarte, CaliforniaCity of Hope Medical Center
Sep 20, 2023
Idiopathic Refractory Scleritis Trial (Infliximab, Cyclophosphamide)
Withdrawn
- Idiopathic Refractory Scleritis
- Infliximab
- Cyclophosphamide
- (no location specified)
Jul 18, 2022
Chronic Granulomatous Disease Transplant Trial run by the NIAID (drug, radiation, biological)
Active, not recruiting
- Chronic Granulomatous Disease Transplant
- Alemtuzumab
- +5 more
-
Bethesda, MarylandNational Institutes of Health Clinical Center
Jan 21, 2023
Large B-Cell Lymphoma Trial in Xi'an (Glofitamab, Polatuzumab vedotin, Rituximab)
Not yet recruiting
- Large B-Cell Lymphoma
- Glofitamab
- +5 more
-
Xi'an, ChinaFirst Affiliated Hospital of Medical College of Xi'an Jiaotong U
Sep 14, 2023
Idiopathic Membranous Nephropathy Trial (Rituximab, Cyclophosphamide)
Not yet recruiting
- Idiopathic Membranous Nephropathy
- Rituximab
- Cyclophosphamide
- (no location specified)
Aug 22, 2022
Graft Vs Host Disease Trial in New York (Cyclophosphamide, Abatacept, Tacrolimus)
Recruiting
- Graft Vs Host Disease
- Cyclophosphamide
- +2 more
-
New York, New YorkNYU Langone Health
Nov 10, 2022
Bone Marrow Transplant Complications, Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia, Adult Trial in Indianapolis
Not yet recruiting
- Bone Marrow Transplant Complications
- +4 more
- Sitagliptin
- +2 more
-
Indianapolis, IndianaIndiana University Melvin and Bren Simon Comprehensive Cancer Ce
May 30, 2023
Advanced Soft-tissue Sarcoma, Metastatic Soft-tissue Sarcoma Trial in Toulouse (Doxorubicin, Cyclophosphamide)
Recruiting
- Advanced Soft-tissue Sarcoma
- Metastatic Soft-tissue Sarcoma
- Doxorubicin
- Cyclophosphamide
-
Toulouse, FranceInstitut Claudius Reagaud-IUCT Oncopôle
Oct 6, 2022
Lipodystrophy Acquired, Type1diabetes Trial in Shanghai (Cyclophosphamide)
Recruiting
- Lipodystrophy Acquired
- Type1diabetes
- Cyclophosphamide
-
Shanghai, Shanghai, ChinaChildren's Hospital of Fudan University
Jul 20, 2022
Ann Arbor Stage III Non-Hodgkin Lymphoma, Ann Arbor Stage IV Non-Hodgkin Lymphoma, Solid Tumor Trial in New Brunswick
Active, not recruiting
- Ann Arbor Stage III Non-Hodgkin Lymphoma
- +2 more
- Cyclophosphamide
- +4 more
-
New Brunswick, New JerseyRutgers Cancer Institute of New Jersey
Jan 28, 2023
Pleural Mesothelioma Trial in Toronto (Cyclophosphamide, Fludarabine, Autologous tumor infiltrating lymphocytes (TILs))
Completed
- Pleural Mesothelioma
- Cyclophosphamide
- +3 more
-
Toronto, Ontario, CanadaPrincess Margaret Cancer Centre
Jan 8, 2023
Refractory Solid Tumor, Hepatocellular Carcinoma, Malignant Solid Tumor Trial in Memphis (Atezolizumab, Sorafenib, Bevacizumab)
Recruiting
- Refractory Solid Tumor
- +4 more
- Atezolizumab
- +3 more
-
Memphis, TennesseeSt. Jude Children's Research Hospital
Aug 4, 2022
Primary Immune Deficiency Disorder, Immune Deficiency Disease, Bone Marrow Failure Trial in Baltimore (Alemtuzumab, Fludarabine,
Recruiting
- Primary Immune Deficiency Disorder
- +2 more
- Alemtuzumab
- +6 more
-
Baltimore, MarylandJohns Hopkins University
Oct 20, 2022
Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia, Chronic Myelomonocytic Leukemia Trial in Duarte (drug, procedure, other)
Recruiting
- Acute Lymphoblastic Leukemia
- +6 more
- Cyclophosphamide
- +4 more
-
Duarte, CaliforniaCity of Hope Medical Center
Dec 8, 2022
Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma Trial in Houston (Cyclophosphamide, Fludarabine Phosphate, Ibrutinib)
Active, not recruiting
- Chronic Lymphocytic Leukemia
- Small Lymphocytic Lymphoma
- Cyclophosphamide
- +3 more
-
Houston, TexasM D Anderson Cancer Center
Aug 18, 2022
Severe Aplastic Anemia (SAA), Hypo-Plastic Myelodysplastic Syndrome (MDS), Paroxysmal Nocturnal Hemoglobinuria (PNH) Trial run
Recruiting
- Severe Aplastic Anemia (SAA)
- +2 more
- Cyclophosphamide
- Peripheral Blood Stem Cells
-
Bethesda, MarylandNational Institutes of Health Clinical Center
Jan 28, 2023